ArticlemedRxiv : the preprint server for health sciences2023
Latent EBV impairs immune cell signaling and enhances the efficacy of anti-CD3 mAb in Type 1 Diabetes.
Ana Lledo Delgado et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.